Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out the highest tolerated dose of Depakote in
combination with liposome encapsulated all-trans retinoic acid (ATRA-IV) in patients with
advanced solid tumor malignancies.